John Kim - Access Bio Managing Partner

950130 Stock  KRW 6,600  100.00  1.54%   

Insider

John Kim is Managing Partner of Access Bio
Phone732 873 4040
Webhttp://www.accessbiodiagnostics.net

John Kim Latest Insider Activity

Tracking and analyzing the buying and selling activities of John Kim against Access Bio stock is an integral part of due diligence when investing in Access Bio. John Kim insider activity provides valuable insight into whether Access Bio is net buyers or sellers over its current business cycle. Note, Access Bio insiders must abide by specific rules, including filing SEC forms every time they buy or sell Access Bio'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Access Bio Management Efficiency

The company has return on total asset (ROA) of 0.3467 % which means that it generated a profit of $0.3467 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 108.0209 %, meaning that it generated $108.0209 on every $100 dollars invested by stockholders. Access Bio's management efficiency ratios could be used to measure how well Access Bio manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 10.13 M in total debt with debt to equity ratio (D/E) of 0.13, which may suggest the company is not taking enough advantage from borrowing. Access Bio has a current ratio of 16.15, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Access Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Access Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Access Bio sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Access to invest in growth at high rates of return. When we think about Access Bio's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 13 records

INSIDER Age

DongWook LeePhoenix Materials Co
62
KyungSoon ChaNewFlex Technology Co
63
MyungHee HwangNewFlex Technology Co
73
ChanKyu HwangNewFlex Technology Co
69
SeokYong ShinNewFlex Technology Co
N/A
YongHo EomNewFlex Technology Co
58
YongHo LimNewFlex Technology Co
N/A
WooHyun LimNewFlex Technology Co
69
BonHun KooPhoenix Materials Co
60
YoungSun ChoiPhoenix Materials Co
60
SeungWon SeoNewFlex Technology Co
64
Lee SeWonNewFlex Technology Co
64
InHo ChoiPhoenix Materials Co
63
Access Bio, Inc. researches, develops, and manufactures in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products. Access Bio (950130) is traded on KOSDAQ in Korea and employs 69 people.

Management Performance

Access Bio Leadership Team

Elected by the shareholders, the Access Bio's board of directors comprises two types of representatives: Access Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Access. The board's role is to monitor Access Bio's management team and ensure that shareholders' interests are well served. Access Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Access Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Andrew Gorman, B Board
Terry Kim, Chief Africa
Philip CPA, Treasurer Board
John Kim, Managing Partner
N MD, Clinical Board
YoungHo Choi, CEO Pres
Janet Strong, DODG Board

Access Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Access Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Access Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Access Bio's short interest history, or implied volatility extrapolated from Access Bio options trading.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Access Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Access Bio information on this page should be used as a complementary analysis to other Access Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Access Stock analysis

When running Access Bio's price analysis, check to measure Access Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Access Bio is operating at the current time. Most of Access Bio's value examination focuses on studying past and present price action to predict the probability of Access Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Access Bio's price. Additionally, you may evaluate how the addition of Access Bio to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Please note, there is a significant difference between Access Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Access Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Access Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.